Coller Competition- Event 10/3 Founders Connect: The Scientific Routes For The Future
Founders Connect: The Scientific Routes For The Future
Live Presentations & Networking session
Overview
An inspiring evening of meeting, mingling, and meaningful discussion where entrepreneurs and scientists connect
* Registration is mandatory
Tuesday, March 10th at 18:00 EY offices, Midtown, Menachem Begin 144, Tel Aviv
At this meetup, leading researchers present short, sharp talks designed for entrepreneurs and founders looking for their next big opportunity.
The focus - climate technologies and innovations that remove animals from industrial supply chains, from alternative proteins to advanced materials and sustainable production systems.
Expect clear insights, real data, and direct access to the people building tomorrow’s solutions.
If you’re a founder looking for scalable impact - or a scientist ready to see your research move into the market - this is where the conversation starts.
Agenda
· Mingling
· Presentations by the researchers
· Networking
Speakers
(The list will be updated soon)
· Ronit Satchi-Fainaro
Head of Gray School of Medical Sciences / Tel Aviv University
· Prof. Ben M. Maoz
Principal Investigator / Tel Aviv University
· Dr. Dan Schneier
Ph.D. researcher / Tel Aviv University
More
** Ronit Satchi-Fainaro
Ronit Satchi-Fainaro is a Full Professor of Pharmacology and of Biomedical Engineering. She is the Head of the Gray School of Medical Sciences at Tel Aviv University. She leads the Cancer Research & Nanomedicine Lab, directs TAU and its 18-affiliated hospitals’ Cancer Biology Research Center, and TAU Kahn 3D BioPrinting Initiative, and holds the Kurt & Herman Lion Chair in Nanoscience & Nanotechnology. She has authored >170 papers and >100 patents, founded 3 companies, and currently runs 2 clinical trials at Sheba Medical Center. She has given >620 invited lectures, and educated >80 graduate students and postdocs pursuing careers in academia, industry, and government. She earned a B.Pharm. (Hebrew Univ., 1995) and Ph.D. (Univ. of London, 1999) in polymer chemistry and cancer nanomedicine, completed postdoctoral training in Cancer & Vascular Biology at Harvard Medical School, and joined TAU in 2006.
About the research:
Prof. Satchi-Fainaro's multidisciplinary research laboratory focuses on basic research elucidating the mechanisms underlying the switch from cancer dormancy to metastatic disease, leading to the discovery of new molecular targets to interrupt tumor-host interactions. Her approach is followed by the design of targeted molecules integrating engineering, biology, chemistry, medicine, bioinformatics, and nanotechnology to guide drugs into pathological sites
** Prof. Maoz is a faculty member at the Sagol School of Neuroscience and the Department of Biomedical Engineering at Tel Aviv University. His lab focuses on developing advanced models for studying human physiology, iPSC and Organs-on-a-Chip. Prof. Maoz received number of prestigious fellowships, awards and honors, such as the Harvard-Wyss Technology Fellowship, Azrieli Fellowship for Academic Excellence and Leadership, ERC grant, recently he was chosen by “The Marker” as the most promising 40 under 40 and he gave a talk in the first metaverse TedX
About the research:
Between 60 to 90% of the drugs that successfully pass animal trials fail in human clinical trials. This poor statistic demonstrates the urgent need for a human-relevant model. In our lab, we develop state of the art tools, known as Organs-on-Chips, which recapitulate human physiology and drug responses. Integrating this technology with unique cells, known as iPSC, allows the creation of personalized medicine, drug development without the use of animals, and identifying drugs for rare diseases.
** Dr. Dan Schneier is an electrochemist and materials engineer, with specialization in lithium-ion batteries. His experience includes synthesis and characterization of new battery components, as well as tool development and implementation for various forms of electrochemical characterization of whole cells. During his work in the Israeli academia and the battery industry, he has led scientific developments from conceptualization, through experiment design, to fulfilment and scale-up.
About the research:
Lithium ion batteries are currently the most ubiquitous energy storage system in the world, powering everything from phones to trucks. The manufacturing of battery electrodes usually entails casting a solvated suspension on the metal current collectors. This research project aims to develop an innovative method to produce Lithium-ion batteries without the use of toxic and wasteful solvents, by using simultaneous extrusion for all battery components. This continuous process would be time, energy and cost efficient , and can be applied for the general LIB industry.
The extrusion process also incorporates a non-PFA polymer in all active components, making the batteries produced this way not only greener and cost-effective to make, but also simpler to recycle.
See you soon!
To Register
